27 Apr 2023 Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis Member news
26 Apr 2023 VIB and Ghent University develop new mRNA vaccines against bacterial infections Member news
24 Apr 2023 Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture Member news
17 Apr 2023 argenx and Genmab enter partnership to advance antibody therapies in immunology and oncology Member news
04 Apr 2023 Biocartis and APIS Assay Technologies sign collaboration to develop and commercialise a breast cancer subtyping test on the Idylla™ platform Member news
30 Mar 2023 Confo Therapeutics enters into collaboration agreement with Daiichi Sankyo to discover novel medicines for CNS diseases Member news
29 Mar 2023 ImmuneWatch, Quantoom Biosciences (Univercells) and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines Member news
20 Mar 2023 Bimekizumab Phase 3 data in hidradenitis suppurativa show clinically meaningful, deep and maintained response over 48 weeks Member news
16 Mar 2023 Aitia and UCB announce strategic drug discovery collaboration in Huntington's Disease Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
